Deals
DaVita to Pay $4.42 Billion for HealthCare Partners
This article is for subscribers only.
DaVita Inc., a provider of kidney dialysis care, agreed to buy HealthCare Partners for about $4.42 billion in cash and stock to expand into broader medical services. The shares rose.
DaVita will pay $3.66 billion in cash plus 9.38 million shares of its stock, which had a value of $758 million as of May 18, for HealthCare Partners, the companies said today in a statement. Closely held HealthCare Partners will run as a separate subsidiary of Denver-based DaVita once the acquisition is completed.